Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG

Pathobiology

Volumn 76, Issue 4, 2009, Pages 181-192

  Li, Xiaomei ^a   Cai, Limin ^b   Chen, Hui ^a   Zhang, Qingyuan ^a   Zhang, Shujun ^a   Wang, Yanhua ^b   Dong, Yanyan ^a   Cheng, Hui ^a   Qi, Jiping ^a,b  

^a Departments of Pathology   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glioma; Inhibitor of growth 4; Proliferation; Tumor suppressor

Indexed keywords

INHIBITOR OF GROWTH 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA; GLIOMA CELL; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 67651122953     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218334     Document Type: Article

References (20)

1. Garkavtsev I, Kazarov A, Gudkov A:Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 1999;14:415-420.
2. Garkavtsev I, Riabowol K:Extension of the replicative lifespan of human diploid fibro-blasts by inhibition of the p33ING1 candidate tumour suppressor. Mol Cell Biol 1997;17:2014-2019.
3. Garkavtsev I, Grigorian IA, Ossovskaya VS:The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 1998;391:295-298.
4. Nagashima M, Shiseki M, Miura K:DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetyla-tion of p53. Proc Natl Acad Sci USA 2001;98:9671-9676.
5. Fe ng X , H a ra Y, R i abowol K:Di f fere nt H ATS of the ING1 gene family. Trends Cell Biol 2002;12:532-538.
6. Leung KM, Po LS, Tsang FC:The candidate tumour suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res 2002;62:4890-4893.
7. Shiseki M, Nagashima M, Pedeux RM:p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 2003;63:2373-2378.
8. Nagashima M, Shiseki M, Pedeux RM:A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 2003;22:343-350.
9. Shimada Y, Saito A, Suzuki M:Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor. Cytogenet Cell Genet 1998;83:232-235.
10. He GH, Helbing CC, Wagner MJ:Phyloge-netic analysis of the ING family of PHD finger proteins. Mol Biol Evol 2005;22:104-116.
11. Garkavtsev I, Kozin SV, Chernova O:The candidate tumour suppressor protein ING4 regulates brain tumour growth and angio-genesis. Nature 2004;428:328-332.
12. Kim S, Chin K, Gray JW:A screen for genes that suppress loss of contact inhibition:identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004;101:16251-16256.
13. Gunduz M, Nagatsuka H, Demircan K:Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005;356:109-117.
14. Li X, Cai L, Liang M, Wang Y:ING4 induces cell growth inhibition in human lung adeno-carcinoma A549 cells by means of Wnt-1/β-catenin signaling pathway. Anat Rec 2008;291:593-600.
15. Maher EA, Furnari FB, Bachoo RM:Malignant glioma:genetics and biology of a grave matter. Genes Dev 2001;15:1311-1333.
16. Campos EI, Chin MY, Kuo WH:Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 2004;61:2597-2613.
17. Zhang X, Xu LS, Wang ZQ:ING4 induces G2/M cell cycle arrest and enhances the che-mosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett 2004;570:7-12.
18. Coats S, Flanagan WM, Nourse J:Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996;272:877-880.
19. Möbius C, Stein HJ, Spiess C:COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol 2005;31:755-759.
20. Oh KJ, Lee SC, Choi HJ:Role of phospholi-pase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J Cell Biochem 2007;101:1409-1422.